Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Menopausal Depression
NCT01117857Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of duloxetine in major depressive disorder (MDD) and vasomotor symptoms, sponsored by Massachusetts General Hospital. Primary endpoint: Hamilton Rating Scale for Depression at 9 weeks. Started Aug 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)vasomotor symptoms
Beyond the preview
Go deeper on NCT01117857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01117857.